Vikas Goyal

Company: Longwood Funds

Job title: Partner

Bio:

Vikas Goyal is a Partner at Longwood Fund, leading growth-stage investments in late preclinical and clinical-stage biotechnology companies. With over 20 years in biotech venture capital and business development, he has held senior roles at SR One and Pandion Therapeutics, where he guided the company through a partnership with Astellas, an IPO, and its $1.85B acquisition by Merck. Vikas earned his MBA in Health Care Management from the Wharton School and a BA in Neurobiology from Harvard University. He is a Kauffman Fellow and serves on the board of the Wharton Health Care Alumni Association. 

Seminars:

Investor Icebreaker: When Being Selective, What Will Investors Choose? 11:30 am

Understanding venture focus across asset-centred investments and early-stage innovation to guide strategic investment discussions Discussing preferences for broad platforms or highly specific assets to understand asset maximization from a venture perspective Identifying exciting modalities, underestimated modalities and targets gaining traction in the global market to anticipate the next wave of autoimmune innovationRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.